Please login to the form below
Medeconnect
This page shows the latest Medeconnect news and features for those working in and with pharma, biotech and healthcare.
AbbVie looks to put bronchiolitis awareness back on the agenda
A survey carried out this year by MedeConnect Healthcare Insights on behalf of AbbVie found that on average paediatricians spend 45% of their time during winter months looking after children with
Latest news
-
Doctors.net.uk launches network of networks
medeConnect, an independent division of Doctors.net.uk, is acting as market research and insight partner to Networks in Health.
-
2011 BOBI awards - winners and pictures
Winner:Lucy Ireland, medeConnect Healthcare Insight. . 10th May 2011.
-
Sweet taste of victory
This analysis is based on research conducted by medeConnect Healthcare Insight, which is part of the doctors.net.uk group.
-
Joint leaders of the pack
Abbott and Roche lead the pack for rheumatologists in the latest medeConnect survey. ... Rheumatologists are the fifth of the speciality doctor groups to have been surveyed by medeConnect Healthcare Insight - part of the Doctors.net.uk group.
-
Straight from the heart
Pfizer impresses in medeConnect survey of cardiologists' views of companies and brands. ... Cardiologists are the fourth of the speciality doctor groups to have been surveyed by medeConnect Healthcare Insight - part of the Doctors.net.uk group.
More from news
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
M3 recruits Google’s former industry head of healthcare
Its new European division will operate Doctors.net.uk, MDLinx (Europe), Networks in Health, medeConnect and the M3 Global Research Panel.
-
Hall & Partners announces new senior hires
2011. Ireland joins from medeConnect, where she was research director. Lee Gazey, managing partner, H&P Health, commented: “Chris and Lucy are two well-known and well-respected figures in our
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
How do doctors spend their time online?
A total of 1, 008 UK GPs took part in the omnibus survey, which was conducted by medeConnect, and their responses are analysed in this essay.
-
M3 (EU)
M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins
-
How can pharma deliver real value to doctors and earn their trust?
The research was carried out for Doctors.net.uk by its independent market research division – medeConnect.
-
Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…
M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
